Clinical Risk Management of Interactions Between Natural Products and Drugs

Author(s): Peter A.G.M. De Smet, Annemieke Floor-Schreudering, Marcel L. Bouvy, Michel Wensing

Journal Name: Current Drug Metabolism

Volume 9 , Issue 10 , 2008

Become EABM
Become Reviewer


Clinical risk management offers a systematic approach to minimize healthcare-related risks by paying attention to: (1) risk identification and assessment; (2) development and execution of risk reduction strategies; (3) evaluation of risk reduction strategies. This paper reviews these key areas for the risk of interactions between natural products and drugs (NPDIs) to explore how the impact of these interactions on public health can be minimized. It argues that specific components of clinical risk management need to be evaluated, before adoption, and then actively implemented if proven valuable.

Keywords: Herb-drug interactions, risk management

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2008
Page: [1055 - 1062]
Pages: 8
DOI: 10.2174/138920008786927730
Price: $65

Article Metrics

PDF: 6